Eurofins Scientific SE:企業の戦略・SWOT・財務情報

◆英語タイトル:Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4456
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ルクセンブルク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Eurofins Scientific SE – Strategy, SWOT and Corporate Finance Report
Summary

Eurofins Scientific SE – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Eurofins Scientific SE (Eurofins or ‘the company’) is a life sciences company that is primarily involved in providing a range of analytical testing services to its clients across multiple industries. These comprise of food and feed testing services, REACH services, genomic services and pharma services, for a few. Eurofins analytical methods help in analyzing and evaluating the safety, identity, composition, origin, authenticity and purity of various biological products and substances. The company operates in Europe, the Americas and Asia Pacific. Eurofin is headquartered in Luxembourg City, Luxembourg.

Scope

- Detailed information on Eurofins Scientific SE required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eurofins Scientific SE in the form of a SWOT analysis
- An in-depth view of the business model of Eurofins Scientific SE including a breakdown and examination of key business segments
- Intelligence on Eurofins Scientific SE’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eurofins Scientific SE, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Eurofins Scientific SE and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Eurofins Scientific SE as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Eurofins Scientific SE’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Eurofins Scientific SE: Company Overview 9
Eurofins Scientific SE: Overview and Key Facts 9
Eurofins Scientific SE: Overview 9
Eurofins Scientific SE: Key Facts 9
Eurofins Scientific SE: Key Employees 10
Eurofins Scientific SE: Key Employee Biographies 12
Eurofins Scientific SE: Major Products and Services 14
Eurofins Scientific SE: Company History 15
Eurofins Scientific SE: Management Statement 23
Eurofins Scientific SE: Locations and Subsidiaries 26
Eurofins Scientific SE: Key Competitors 28
Eurofins Scientific SE: Company Analysis 29
Eurofins Scientific SE: Business Description 29
Eurofins Scientific SE: SWOT Analysis 31
Eurofins Scientific SE: SWOT Overview 31
Eurofins Scientific SE: Strengths 31
Eurofins Scientific SE: Weaknesses 32
Eurofins Scientific SE: Opportunities 32
Eurofins Scientific SE: Threats 33
Eurofins Scientific SE: Corporate Financial Deals Activity 34
Eurofins Scientific SE: Financial Deals Overview 34
Eurofins Scientific SE: Targets and Partners 36
Eurofins Scientific SE: Top Deals 2014 – 2018YTD* 40
Eurofins Scientific SE: Advisors 41
Eurofins Scientific SE: Top Legal Advisors 41
Eurofins Scientific SE: Top Financial Advisors 41
Eurofins Scientific SE: Mergers and Acquisitions 42
Eurofins Scientific SE: Capital Raising 43
Eurofins Scientific SE: Partnership 44
Eurofins Scientific SE: Private Equity and Ownership 45
Eurofins Scientific SE: Recent Developments 46
Eurofins Scientific SE: News and Events Summary 46
Eurofins Scientific SE: Contracts 50
Eurofins Scientific SE: Financial Deals 52
Eurofins Scientific SE: Financial Performance 53
Eurofins Scientific SE: Strategy and Operations 53
Appendix 55
Contact Us 55
Methodology 55
About MarketLine 56

List of Tables
Table 1: Eurofins Scientific SE: Key Facts
Table 2: Eurofins Scientific SE: Key Employees
Table 3: Eurofins Scientific SE: Locations and Subsidiaries
Table 4: Eurofins Scientific SE: Key Competitors
Table 5: Eurofins Scientific SE: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Eurofins Scientific SE: M&A Activity by Geography (TTM*)
Table 7: Eurofins Scientific SE: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Eurofins Scientific SE: M&A Average Deal Size - Value (US$m)
Table 9: Eurofins Scientific SE: Targets and Partners
Table 10: Eurofins Scientific SE: Top Deals 2014 - 2018YTD*
Table 11: Eurofins Scientific SE: Legal Advisor Ranking by Value (US$m)
Table 12: Eurofins Scientific SE: Financial Advisor Ranking by Value (US$m)
Table 13: Eurofins Scientific SE: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Eurofins Scientific SE: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Eurofins Scientific SE: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Eurofins Scientific SE: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Eurofins Scientific SE: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Eurofins Scientific SE: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Eurofins Scientific SE: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Eurofins Scientific SE: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Eurofins Scientific SE: News and Events Summary
Table 22: Eurofins Scientific SE: Contracts
Table 23: Eurofins Scientific SE: Financial Deals
Table 24: Eurofins Scientific SE: Financial Performance
Table 25: Eurofins Scientific SE: Strategy and Operations

List of Figures
Figure 1: Eurofins Scientific SE: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Eurofins Scientific SE: M&A Activity by Geography (TTM*)
Figure 3: Eurofins Scientific SE: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Eurofins Scientific SE: M&A Average Deal Size - Value (US$m)
Figure 5: Eurofins Scientific SE: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Eurofins Scientific SE: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Eurofins Scientific SE: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Eurofins Scientific SE: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Eurofins Scientific SE: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Eurofins Scientific SE: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Eurofins Scientific SE: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Eurofins Scientific SE: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Eurofins Scientific SE:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Community Health Systems Inc (CYH)-製薬・医療分野:企業M&A・提携分析
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • Archrock Partners LP:企業のM&A・事業提携・投資動向
    Archrock Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Archrock Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Meiji Yasuda Life Insurance Company:企業の戦略・SWOT・財務情報
    Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Xeltis AG:企業の製品パイプライン分析2018
    Summary Xeltis AG (Xeltis) is a clinical-stage medical equipment company that harnesses advances in science to improve the treatment of heart valve related conditions. The company’s polymer-based technology platform, RestoreX, facilitates the natural restoration of heart valve through a process refe …
  • Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • Tata Power Solar Systems Ltd:企業の戦略的SWOT分析
    Tata Power Solar Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the app …
  • DEINOVE SA (ALDEI):製薬・医療:M&Aディール及び事業提携情報
    Summary Deinove SA (Deinove) is a biotech company that discovers, develops and produces compounds. The company combines its biological assets and its metabolic engineering technology in three fields of application including healthcare, nutrition and cosmetics. Its healthcare application provides res …
  • United Continental Holdings Inc:戦略・SWOT・企業財務分析
    United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Marubeni Corp (8002):企業の財務・戦略的SWOT分析
    Marubeni Corp (8002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vanderbilt University Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Vanderbilt University Medical Center (VUMC), a subsidiary of Vanderbilt University is a healthcare service provider that offers patient care, research and bio-medical education. The center’s services include adult emergency services, case management, corporate health services, adult psychiat …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • Children’s Medical Center:企業の戦略的SWOT分析
    Children's Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Paoli Calmettes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Paoli Calmettes Institute (IPC) is a cancer treatment institute. The institute provides medical activities such as consultations, imaging examinations, chemotherapy preparations, radiotherapy sessions, surgical stays, endoscopies, and bone marrow and stem cell transplants. Its areas of disti …
  • Abivax SA (ABVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Abivax SA (Abivax) is a biotechnology company that develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to induce f …
  • TAS Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary TAS Energy, Inc. (TAS), formerly Turbine Air Systems, Ltd., offers clean and modular energy solutions. The company designs, manufactures and supplies turbine inlet chilling systems for power augmentation; modular utility systems for air cooling; waste heat/geothermal systems for power genera …
  • Oberbank AG:企業の戦略・SWOT・財務分析
    Oberbank AG - Strategy, SWOT and Corporate Finance Report Summary Oberbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ABPA Holdings Limited:企業の戦略的SWOT分析
    ABPA Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Actuate Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actuate Therapeutics Inc (Actuate Therapeutics) is a biopharmaceutical company that offers development of novel compounds for the treatment of cancer and inflammatory diseases. The company’s lead compound 9-ING-41 is under evaluation for anti-tumor activity in various vivo models. It also de …
  • Bouygues Group:戦略・SWOT・企業財務分析
    Bouygues Group - Strategy, SWOT and Corporate Finance Report Summary Bouygues Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆